Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM Tags Diabetic Nephropathy FBS GLP-1 agonists hBA1c Read more about Semaglutide Added to Insulin Improved Glycemic, Renal Measures in T2DM
Orforglipron Demonstrated Dose-Dependent GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Demonstrated Dose-Dependent GI Adverse Events
Orforglipron Shows Dose-Related GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Shows Dose-Related GI Adverse Events
ECO 2026: Meta-Analysis Links Obesity Drugs to Lower Blood Pressure Tags Hypertension GLP-1 agonists Read more about ECO 2026: Meta-Analysis Links Obesity Drugs to Lower Blood Pressure
ECO 2026: Women Using Semaglutide Showed Reduced Triptan Use Tags GLP-1 agonists Read more about ECO 2026: Women Using Semaglutide Showed Reduced Triptan Use
ECO 2026: GLP-1 Therapy Linked to Fewer Asthma Exacerbations Tags GLP-1 agonists Read more about ECO 2026: GLP-1 Therapy Linked to Fewer Asthma Exacerbations
ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment Tags GLP-1 agonists Read more about ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment
ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass Tags GLP-1 agonists Read more about ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass
ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity Tags GLP-1 agonists Read more about ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity
ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss Tags GLP-1 agonists Read more about ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss